1. Molecular mechanisms of aging-associated decline in stem cell function and their relevance to cancer.
2. Aging-associated DNA damage response pathways and genomic instability in cancer.
3. Epigenetic mechanism in aging and cancer.
4. Contributions of the microenvironment in aging-associated tumor formation.
5. Human premature aging disorders as model systems of aging-associated cancer formation.
6. Cancer intervention based on aging mechanisms.
Jian-Jun Chen, University of Cincinnati, USA
Saijuan Chen, Shanghai Jiaotong University, CHINA
Zhu Chen, Shanghai Institute of Hematology, CHINA
Hugues de Thé, Collège de France, FRANCE
Cynthia Dunbar, National Heart, Lung, & Blood Institute, NIH, USA
Margaret Goodell, Baylor College of Medicine, USA
Anne Janin, Université Paris Diderot, FRANCE
Saadi Khochbin, Alpes University Institute for Advanced Biosciences, FRANCE
Jonathan Licht, Northwestern University, USA
Ryuzo Ohno, Aichi Cancer Center Hospital, JAPAN
Pier-Paolo Pandolfi, Harvard Medical School, USA
Ruibao Ren, Shanghai Jiao-Tong University School of Medicine, CHINA
Amy Wagers, Harvard Medical School, USA
Samuel Waxman, The Mount Sinai Medical Center, USA
Arthur Zelent, University of Miami Health System, USA
We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (talk/poster) of abstracts will be posted on this web site as soon as decisions have been made by the organizers.
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs attending the conference will be selected for fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html
We look forward to seeing you at Suzhou in November, 2017.